Carl Zeiss (Germany) Today
| AFX Stock | 59.05 0.20 0.34% |
Performance2 of 100
| Odds Of DistressLess than 9
|
Carl Zeiss is selling for under 59.05 as of the 3rd of February 2025; that is 0.34 percent increase since the beginning of the trading day. The stock's last reported lowest price was 57.8. Carl Zeiss has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 14th of February 2023 and ending today, the 3rd of February 2025. Click here to learn more.
Carl Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Carl Zeiss' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Carl Zeiss or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Carl Zeiss Meditec (AFX) is traded on XETRA Stock Exchange in Germany and employs 4,224 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Carl Zeiss's market, we take the total number of its shares issued and multiply it by Carl Zeiss's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Carl Zeiss Meditec operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 89.44 M outstanding shares.
Carl Zeiss generates positive cash flow from operations, but has no cash available
Check Carl Zeiss Probability Of Bankruptcy
Ownership AllocationCarl Zeiss holds a total of 89.44 Million outstanding shares. Carl Zeiss Meditec retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Carl Ownership Details
Carl Zeiss Meditec Risk Profiles
Although Carl Zeiss' alpha and beta are two of the key measurements used to evaluate Carl Zeiss' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.14 | |||
| Standard Deviation | 3.04 | |||
| Variance | 9.25 | |||
| Risk Adjusted Performance | (0.01) |
Carl Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Carl Zeiss without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Carl Zeiss Corporate Management
Elected by the shareholders, the Carl Zeiss' board of directors comprises two types of representatives: Carl Zeiss inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carl. The board's role is to monitor Carl Zeiss' management team and ensure that shareholders' interests are well served. Carl Zeiss' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carl Zeiss' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sebastian Frericks | Director Relations | Profile | |
| Laurie Ferguson | Head Devices | Profile | |
| Markus Weber | CEO Pres | Profile | |
| Martin Wiechmann | Head Unit | Profile | |
| Andrew Chang | I Meditec | Profile | |
| Euan Thomson | Pres Unit | Profile | |
| Steven MD | Chief Devices | Profile |
Additional Tools for Carl Stock Analysis
When running Carl Zeiss' price analysis, check to measure Carl Zeiss' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carl Zeiss is operating at the current time. Most of Carl Zeiss' value examination focuses on studying past and present price action to predict the probability of Carl Zeiss' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carl Zeiss' price. Additionally, you may evaluate how the addition of Carl Zeiss to your portfolios can decrease your overall portfolio volatility.